4//SEC Filing
Milligan Sandra 4
Accession 0001209191-23-028100
CIK 0001821825other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 6:43 PM ET
Size
8.7 KB
Accession
0001209191-23-028100
Insider Transaction Report
Form 4
Milligan Sandra
Head of Research & Development
Transactions
- Tax Payment
Common Stock
2023-05-04$24.24/sh−2,168$52,552→ 28,599 total - Exercise/Conversion
Restricted Stock Units
2023-05-04−4,984→ 4,984 totalFrom: 2023-05-04Exp: 2024-05-04→ Common Stock (4,989 underlying) - Exercise/Conversion
Common Stock
2023-05-04+4,984→ 30,767 total
Footnotes (1)
- [F1]1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024.
Documents
Issuer
Organon & Co.
CIK 0001821825
Entity typeother
Related Parties
1- filerCIK 0001859810
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 6:43 PM ET
- Size
- 8.7 KB